Starling Oncology (STLN) EPS (Basic) (QoQ) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) EPS (Basic) (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -288.86% |
| Mar 31, 2026 | 70.43% |
| Dec 31, 2025 | 50.76% |
| Sep 30, 2025 | 5.89% |
| Jun 30, 2025 | 28.00% |
| Mar 31, 2025 | -44.53% |
| Dec 31, 2024 | 17.60% |
| Sep 30, 2024 | -3.22% |
| Jun 30, 2024 | 36.69% |
| Mar 31, 2024 | -5.36% |
| Dec 31, 2023 | -7.26% |
| Sep 30, 2023 | -4.00% |
| Jun 30, 2023 | 44.18% |
| Mar 31, 2023 | -170.10% |
| Dec 31, 2022 | -308.19% |
| Sep 30, 2022 | 50.41% |
| Jun 30, 2022 | -128.37% |
| Mar 31, 2022 | 275.53% |
| Dec 31, 2021 | -1,147.66% |
| Sep 30, 2021 | 95.48% |